DOI: http://dx.doi.org/10.18203/issn.2455-4510.IntJResOrthop20185332

Estimation of prevalence of multidrug resistance in spinal tuberculosis, antibiotic susceptibility patterns and clinical outcomes

Santosh Ghoti, Saurabh Sah, Sajal Mitra, Amol Bochare

Abstract


Background: There are no adequate data in literature referring to the early diagnosis and treatment (especially surgical) of MDR tuberculosis of spine and evaluation of its clinical outcome. We aimed to address this lacunae, by using gene expert test (CBNAAT) and drug sensitivity/susceptibility tests (DST) and by studying subsequent actual clinical outcomes.

Methods: Forty patients with clinico-radiological scenario of spinal tuberculosis were evaluated using biochemical, radiological and histo-pathological studies. Anti-tuberculosis treatment was empirically started based on initial clinico-radiological suspicion of spinal tuberculosis. All tissue specimen and intra-operative samples were subjected to CBNAAT, MGIT culture and histopathological examination. Culture of those samples which showed rifampicin resistance on CBNAAT were followed up for DST (Drug Susceptibility Test) and the treatment modified accordingly, if required. All cases were followed up at 3, 6, 9 and 12 months interval.

Results: Out of 40 patients, mycobacterium tuberculosis was detected in 23 patients by CBNAAT. Out of these 23 cases, 20 showed mycobacterium tuberculosis sensitivity to rifampicin and 3 were resistant. Out of these 3 cases, one had culture positive. Sensitivity and negative predictive value of gene expert test in comparison with the culture were 100%. Specificity and positive predictive value were calculated at 58.6% and 47.8% respectively. Accuracy of gene expert in our study was found to be 70%.

Conclusions: Early detection of MDR spinal tuberculosis using highly sensitive CBNAAT test would be helpful to avoid consequences of inappropriate chemotherapy and would result in favourable outcomes.


Keywords


MDR-TB, Spinal TB, CBNAAT, Drug susceptibility testing

Full Text:

PDF

References


Taylor GM, Murphy E, Hopkins R. First report of mycobacterium tuberculosis bovis DNA in human remain from iron-age. 2007;153(4):1243-9.

Jain AK, Dhammi IK. Tuberculosis of the spine:A review. Clinorthop Related Res. 2007;460(July):39-49.

Jain AK, Dhammi IK, Modi P, Kumar J, Sreenivasan R, and Saini N. Tuberculosis spine:Therapeutically refractory disease. Indian J Orthop. 2012;46(2):171–8.

Shrestha D, Shrestha R, Dhoju D. Fluoroscopy Guided Percutaneous Transpedicular Biopsy for Thoracic and Lumbar Vertebral Body Lesion:Technique and Safety in 23 Consecutive Cases. Kathmandu Univ Med J. 2015;51(3):256-60.

He QY, Xu JZ, Zhou Q, Luo F, Hou T, Zhang Z. Treatment effect, postoperative complications, and their reasons in juvenile thoracic and lumbar spinal tuberculosis surgery. J Orthop Surg Res. 2015;10:156.

Huang J, Zhang H, Zeng K, Gao Q. The clinical outcome of surgical treatment of noncontagious spinal tuberculosis: A Retrospective study in 23 cases. PLos One. 2014;9(4):e93648.

Sharma A, Chhabra HS, Mahajan R, Chhabra T, Batra S. Magnetic Resonance Imaging and GeneXpert: A Rapid and Accurate Diagnostic Tool for the Management of Tuberculosis of the Spine. Asian Spine J. 2016;10(5):850-6.

Litao Li, Zehua Zhang, Fei Luo, Jianzhong Xu, Peng Cheng, Zheng Wu et al. Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy:a retrospective analysis of thirty-five patients Int Orthop (SICOT). 2012;36:277–83.

Tuli SM. Tuberculosis of the skeletal system:bones, joints, spine and bursal sheaths. New Delhi:Jaypee Brothers Pvt. Ltd.; 2010.

Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance Future Microbiol. 2011;6(9):1067–82.

Suzana S, Ninan MM, Gowri M, Venkatesh K, Rupali P, MichaelJS. Xpert MTB/Rif for the diagnosis of extrapulmonary tuberculosis--an experience from a tertiary care centre in South India. Trop Med Int Health. 2016;21(3):385-9.

Scott LE, Beylis N, Nicol MP, Nkuna G, Molapo S, Berrie L, et al. Diagnostic Accuracy of Xpert MTB/RIF for Extrapulmonary Tuberculosis Specimens: Establishing a Laboratory Testing Algorithm for South Africa J ClinMicrobiol. 2014;52(6):1818-23.

Lawn SD, Zumla A. Diagnosis of extrapulmonary tuberculosis using the Xpert MTB/RIF assay. Anti Infect Ther. 2012;2012:631-5.

World Health Organization ‘Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children’. Available at: http://www.who.int/about/licensing/copyright_form/en/index.html. Accessed on 5 September 2018.

The World Health Organization. Union against tuberculosis: Global project on anti-tuberculosis drug resistance surveillance. Fourth Global Report. 2002-2007.

Held M, Laubscher M, Zar HJ, Dunn RN. GeneXpert polymerase chain reaction for spinal tuberculosis. Bone Joint J. 2014;96-B:1366-9.

Kumar M, Kumar R, Srivastava AK, Nag VL, Maurya AK, Dhole TN, et al. Sensitivity of PCR IS6110 in relation to culture and staining in Pott's disease. Indian J Neurosurg. 2013;2:46-51.